Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR TO COLLABORATE WITH TOP 10 GLOBAL PHARMACEUTICAL COMPANY
Arecor expands its global partnerships through collaboration to develop an enhanced antibody formulation
Cambridge, UK, 17 August 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an agreement with a top 10 pharmaceutical company to develop an enhanced antibody formulation for one of its investigational drugs.